Mapping Epitope Characteristics on Carcinoembryonic Antigen

Overview

Journal Br J Cancer

Specialty Oncology

Date 1986 Jul 1

PMID 2425837

Citations 14

Authors

P J Harwood

D W Britton

P J Southall

G M Boxer

G Rawlins

G T Rogers

Affiliations

Soon will be listed here.

Abstract

A method of epitope analysis is described in which the binding of one monoclonal antibody (MAb) to radiolabeled carcinoembryonic antigen (CEA) competes with the subsequent binding of an immobilised second MAb. From the degree of blocking obtained, we have identified both structurally related and independent epitopes on CEA. Using this technique to study fifteen MAbs, we have been able to recognise at least 6 unrelated epitopes of the CEA glycoprotein. Further characterisation of these epitopes was accomplished by means of immunohistochemistry. Of the fifteen MAbs, 6 were specific for CEA and reacted with at least 3 unrelated regions of the glycoprotein. Of the remaining 9 MAbs, 2 cross-reacted with erythrocytes, 5 with components of liver and 7 with polymorphonuclear neutrophils. Cross-reactions with liver were varied showing differential antibody specificity for bile canaliculi, Kupffer cells and bile duct epithelium. A high degree of correlation between epitope relatedness and immunohistochemical specificity was found. Two CEA-specific and 4 cross-reactive MAbs were also shown to react with ion-sensitive sites on the CEA glycoprotein.

Citing Articles

The CEA/CD3-bispecific antibody MEDI-565 (MT111) binds a nonlinear epitope in the full-length but not a short splice variant of CEA.

Peng L, Oberst M, Huang J, Brohawn P, Morehouse C, Lekstrom K PLoS One. 2012; 7(5):e36412.

PMID: 22574157 PMC: 3344869. DOI: 10.1371/journal.pone.0036412.

Radioimmunoluminography: a tool for relating tissue antigen concentration to clinical outcome.

Boxer G, Flynn A, Green A, Begent R Br J Cancer. 1999; 80(5-6):922-6.

PMID: 10360677 PMC: 2362277. DOI: 10.1038/sj.bjc.6690443.

Radioimmunotherapy of colorectal carcinoma xenografts in nude mice with yttrium-90 A33 IgG and Tri-Fab (TFM).

Antoniw P, Farnsworth A, Turner A, HAINES A, Mountain A, Mackintosh J Br J Cancer. 1996; 74(4):513-24.

PMID: 8761364 PMC: 2074671. DOI: 10.1038/bjc.1996.395.

Radioimmunotherapy of metastatic colorectal tumours with iodine-131-labelled antibody to carcinoembryonic antigen: phase I/II study with comparative biodistribution of intact and F(ab')2 antibodies.

Lane D, Eagle K, Begent R, Green A, Casey J, Keep P Br J Cancer. 1994; 70(3):521-5.

PMID: 8080740 PMC: 2033373. DOI: 10.1038/bjc.1994.338.

Antitumor effects of an antibody-carboxypeptidase G2 conjugate in combination with a benzoic acid mustard prodrug.

Blakey D, Valcaccia B, East S, Wright A, Boyle F, Springer C Cell Biophys. 1993; 22(1-3):1-8.

PMID: 7889535 DOI: 10.1007/BF03033863.

References

von Kleist S, Chavanel G, Burtin P . Identification of an antigen from normal human tissue that crossreacts with the carcinoembryonic antigen. Proc Natl Acad Sci U S A. 1972; 69(9):2492-4. PMC: 426972. DOI: 10.1073/pnas.69.9.2492. View

Gold P, Freedman S . DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES. J Exp Med. 1965; 121:439-62. PMC: 2137957. DOI: 10.1084/jem.121.3.439. View

Neville A, Cooper E . Biochemical monitoring of cancer. A review. Ann Clin Biochem. 1976; 13(1):283-305. DOI: 10.1177/000456327601300101. View

Bordes M, Knobel S, Martin F . Carcinoembryonic antigen (CEA) and related antigens in blood cells and hematopoietic tissues. Eur J Cancer (1965). 1975; 11(11):783-6. DOI: 10.1016/0014-2964(75)90171-1. View

Svenberg T . Carcinoembryonic antigen-like substances of human bile. Isolation and partial characterization. Int J Cancer. 1976; 17(5):588-96. DOI: 10.1002/ijc.2910170506. View

Fraker P, SPECK Jr J . Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun. 1978; 80(4):849-57. DOI: 10.1016/0006-291x(78)91322-0. View

Judd M, Britten K . Tissue preparation for the demonstration of surface antigen by immunoperoxidase techniques. Histochem J. 1982; 14(5):747-53. DOI: 10.1007/BF01033624. View

Primus F, Kuhns W, Goldenberg D . Immunological heterogeneity of carcinoembryonic antigen: immunohistochemical detection of carcinoembryonic antigen determinants in colonic tumors with monoclonal antibodies. Cancer Res. 1983; 43(2):693-701. View

Haskell C, Buchegger F, Schreyer M, Carrel S, Mach J . Monoclonal antibodies to carcinoembryonic antigen: ionic strength as a factor in the selection of antibodies for immunoscintigraphy. Cancer Res. 1983; 43(8):3857-64. View

10.

Rogers G, RAWLINS G, Kardana A, Gibbons A . Binding studies on two different monoclonal antibodies raised against CEA. Eur J Cancer Clin Oncol. 1983; 19(5):629-39. DOI: 10.1016/0277-5379(83)90179-7. View

11.

Rogers G . Carcinoembryonic antigens and related glycoproteins. Molecular aspects and specificity. Biochim Biophys Acta. 1983; 695(3-4):227-49. DOI: 10.1016/0304-419x(83)90013-6. View

12.

Dillman R, Beauregard J, Sobol R, Royston I, Bartholomew R, Hagan P . Lack of radioimmunodetection and complications associated with monoclonal anticarcinoembryonic antigen antibody cross-reactivity with an antigen on circulating cells. Cancer Res. 1984; 44(5):2213-8. View

13.

Rogers G, RAWLINS G, Kardana A, Gibbons A, Bagshawe K . A monoclonal antibody against a CEA-related antigen expressed on HT29 colon tumour cells. Eur J Cancer Clin Oncol. 1984; 20(10):1279-86. DOI: 10.1016/0277-5379(84)90257-8. View

14.

Begent R . Recent advances in tumour imaging. Use of radiolabelled antitumour antibodies. Biochim Biophys Acta. 1985; 780(2):151-66. DOI: 10.1016/0304-419x(84)90003-9. View

15.

Burtin P, Chavanel G, HIRSCH-MARIE H . Characterization of a second normal antigen that cross-reacts with CEA. J Immunol. 1973; 111(6):1926-8. View